1. Home
  2. LYEL vs XPOF Comparison

LYEL vs XPOF Comparison

Compare LYEL & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

SELL

Current Price

$13.64

Market Cap

195.8M

Sector

Health Care

ML Signal

SELL

Logo Xponential Fitness Inc.

XPOF

Xponential Fitness Inc.

SELL

Current Price

$4.28

Market Cap

205.6M

ML Signal

SELL

Company Overview

Basic Information
Metric
LYEL
XPOF
Founded
2018
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Services-Misc. Amusement & Recreation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
195.8M
205.6M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
LYEL
XPOF
Price
$13.64
$4.28
Analyst Decision
Buy
Hold
Analyst Count
8
8
Target Price
★ $37.63
$5.30
AVG Volume (30 Days)
212.6K
★ 575.5K
Earning Date
11-04-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 35.24
EPS
N/A
★ N/A
Revenue
$36,000.00
★ $11,092,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.29
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.20
$3.57
52 Week High
$45.00
$9.25

Technical Indicators

Market Signals
Indicator
LYEL
XPOF
Relative Strength Index (RSI) 54.63 44.20
Support Level $12.25 $3.66
Resistance Level $14.97 $5.16
Average True Range (ATR) 1.67 0.33
MACD -0.18 -0.00
Stochastic Oscillator 43.74 42.08

Price Performance

Historical Comparison
LYEL
XPOF

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a franchisor of boutique health and wellness brands. It operates a diversified platform of five brands spanning across verticals, including Pilates, barre, stretching, functional training, and yoga. Through its subsidiary, it offers an energetic, accessible, and personalized workout experience led by qualified instructors in studio locations throughout North America and internationally. The company's portfolio of brands includes Club Pilates; StretchLab; YogaSix; Pure Barre; and BFT. It operates in a single segment of the franchise business of its health and wellness brands.

Share on Social Networks: